Skip to main content
. 2013 Jul 18;27(12):721–728. doi: 10.1038/jhh.2013.68

Figure 3.

Figure 3

Morning home and clinic systolic blood pressure (SBP) in patients with well-controlled, white coat, masked, and poor-controlled hypertension (a) just before and (b) after 16 weeks of olmesartan treatment (n=19 022). There was a significant difference between just before and after 16 weeks of olmesartan treatment (P<0.0001, McNemar's test). The arrow shows the change in average SBP from baseline to 16 weeks.